Table 2.

The Association Between Hip and Total Body DXA Measurements and cIMT Among ALSPAC Study Women

	SD change in cIMT per 1 SD change in exposure (95% CI) (n = 3366)
Exposure	Model 1	p Value	Model 2	p Value	Model 3	p Value
Total hip BMD	0.068 (0.034, 0.102)	<0.001	0.110 (0.077, 0.144)	<0.001	0.063 (0.025, 0.101)	0.001
Femoral neck BMD	0.057 (0.022, 0.091)	0.001	0.105 (0.071, 0.139)	<0.001	0.055 (0.018, 0.091)	0.004
Trochanter BMD	0.089 (0.055, 0.122)	<0.001	0.116 (0.083, 0.150)	<0.001	0.069 (0.032, 0.106)	<0.001
CSMI	0.106 (0.072, 0.140)	<0.001	0.118 (0.085, 0.151)	<0.001	0.052 (0.012, 0.092)	0.011
Total body BMD	0.084 (0.051, 0.119)	<0.001	0.132 (0.099, 0.165)	<0.001	0.071 (0.030, 0.112)	0.001
Total body BA	0.087 (0.053, 0.121)	<0.001	0.117 (0.084, 0.151)	<0.001	0.048 (–0.004, 0.100)	0.071
Total body BMC	0.097 (0.063, 0.131)	<0.001	0.139 (0.105, 0.172)	<0.001	0.076 (0.027, 0.125)	0.003
aBMC	0.124 (0.031, 0.217)	0.009	0.218 (0.128, 0.309)	<0.001	0.152 (0.051, 0.253)	0.003

cIMT = common carotid intima‐media thickness; CI = confidence interval; BMD = bone mineral density; CSMI = cross‐sectional moment of inertia (cm⁴); BA = bone area; BMC = bone mineral content; aBMC = area‐adjusted total body bone mineral content.

Table shows results of linear regression analysis between hip and total body DXA measurements and cIMT in 3366 individuals. Results are standard deviation change in cIMT per standard deviation increase in exposure (95% confidence intervals) and p value. Model 1 = unadjusted analysis; model 2 = adjustment for age; model 3 = model 2 plus additional adjustment for height, lean mass, fat mass, menopause, smoking, hormone replacement, calcium and/or vitamin D supplement use, and education.